In a nutshell This study was looking at which combination of medication is better at treating late-stage melanoma, ziv-aflibercept (Zaltrap) combined with high-dose interleukin-2 (Proleukin) or high-dose interleukin-2 by itself. The study found that using ziv-aflibercept combined with high-dose interleukin-2 was better than using high-dose interleukin-2...
Read MoreType(s) of immunotherapy-Interleukin 2 (IL-2) Posts on Medivizor
Immunotherapy and targeted therapy for advanced melanoma: a review
In a nutshell The authors reviewed immunotherapies and targeted therapies for the treatment of advanced melanoma. Some background In advanced melanoma (stage IV), cancer spreads from the skin to other parts of the body. Immunotherapy and targeted therapy are promising treatment options for this disease. These therapies...
Read MoreInterleukin-2 can improve survival in skin cancer patients
In a nutshell The authors aimed to determine the effect of interleukin-2 in treating in-transit skin cancer. Some background In-transit skin cancer is cancer that has progressed into the lymph nodes (sites that hold the immune cells) from the primary site of cancer. Interleukin-2 (IL-2, Proleukin, Aldesleukin) is a man-made protein...
Read MoreImmunotherapy after chemotherapy shows promising results in advanced melanoma
In a nutshell The authors aimed to determine survival and response rates of patients treated with immunotherapy following regional chemotherapy. Some background Regional chemotherapy is chemotherapy that targets a specific area in the body. It is carried out using isolated limb infusion (isolates blood flow to the limb to allow for a more...
Read More
